Detect and monitor vascular injury with PerkinElmer’s In Vivo Fluorescent Imaging Agents Panel.
true falseYou successfully added item(s) to your cart
For research use only. Not for use in diagnostic procedures.
Vascular injury can have numerous causes, including peripheral vascular disease, thrombosis, aneurysm, atherosclerosis, and drug induced vascular injury. Vascular injury may progress into changes in vascular integrity, remodeling, inflammation, and fibrosis. This panel of fluorescent imaging probes detects cellular and molecular players in vascular pathology, allowing the ability to non-invasively characterize biological changes associated with disease progression or treatment efficacy.
The availability of probes at 680 nm and 750 nm wavelengths further offer the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.
The Vascular In Vivo Fluorescent Agents Panel includes the following five probes:
| Part Number | Fluorescent Probe | Biological Target |
|---|---|---|
| NEV10054EX | AngioSense 680 EX | Vascular probe: Provides vascular contrast or vascular leak imaging |
| NEV10168 | MMPSense 750 FAST | Pan-MMP activatable probe: Secreted protease involved in vascular remodeling and angiogenesis Secreted by vascular inflammatory cells |
| NEV10645 | IntegriSense 680 | αVβ3 integrin targeted probe: Marker on neovasculature and inflammatory cells involved in vascular inflammation |
| NEV11112 | Cat B 680 FAST | Cathepsin B activatable probe: Lysosomal marker of cells in vascular inflammation |
| NEV11171 | ProSense 750 FAST | Pan-cathepsin activatable probe: Lysosomal marker of inflammatory cells in vascular inflammation |
| Optical Imaging Classification | Fluorescence Imaging |
|---|---|
| Quantity in a Package Amount | 5.0 Units |
| Shipping Condition | Blue Ice |
| Therapeutic Area | Vascular disease |
| Unit Size | 1 vial |
Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used to detect tumor leakiness as an indication of abnormal tumor vasculature. Inflammation is also characterized by distinct vascular changes, including vasodilation and increased vascular permeability, which are induced by the actions of various inflammatory mediators. This process is essential for facilitating access for appropriate cells, cytokines, and other factors to tissue sites in need of healing or protection from infection.
Data sheet on PerkinElmer's Fluorescent Panels for In Vivo imaging
User guide for fluorescent imaging probes
